These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 25030278)
21. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site. Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560 [TBL] [Abstract][Full Text] [Related]
22. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer. Escott EJ Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911 [TBL] [Abstract][Full Text] [Related]
23. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
24. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions. Shammas A; Lim R; Charron M Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606 [TBL] [Abstract][Full Text] [Related]
25. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors. Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948 [TBL] [Abstract][Full Text] [Related]
26. The pivotal role of FDG-PET/CT in modern medicine. Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337 [TBL] [Abstract][Full Text] [Related]
27. [Usefulness of 18F-FDG PET/CT examination in the diagnosis of head and neck cancer--preliminary results]. Kuźmińska M; Osuch-Wójcikiewicz E; Fronczewska-Wieniawska K; Królicki L; Niemczyk K Otolaryngol Pol; 2011 Sep; 65(5 Suppl):17-21. PubMed ID: 22000246 [TBL] [Abstract][Full Text] [Related]
28. Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT. Paes FM; Singer AD; Checkver AN; Palmquist RA; De La Vega G; Sidani C Radiographics; 2013 Oct; 33(6):1717-36. PubMed ID: 24108559 [TBL] [Abstract][Full Text] [Related]
29. Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies. Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Coleman RE Radiology; 2007 Jul; 244(1):263-72. PubMed ID: 17495174 [TBL] [Abstract][Full Text] [Related]
30. The potential role of non-FDG-PET in the management of head and neck cancer. Heuveling DA; de Bree R; van Dongen GA Oral Oncol; 2011 Jan; 47(1):2-7. PubMed ID: 21109481 [TBL] [Abstract][Full Text] [Related]
31. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410 [TBL] [Abstract][Full Text] [Related]
32. Imaging by ¹⁸F-FDG PET/CT of diffuse large B-cell lymphoma with cellulitis. Zhang Y; Li B; Cai L; Shi H; Hou J Hell J Nucl Med; 2015; 18(3):271-2. PubMed ID: 26574700 [TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography-computed tomography can be useful in the early detection of metastases in primary mucinous carcinoma of the skin on the head and neck. Kitamura S; Hata H; Inamura Y; Imafuku K; Sakashita T; Hirata K; Shimizu H Br J Dermatol; 2015 Nov; 173(5):1263-5. PubMed ID: 26147882 [TBL] [Abstract][Full Text] [Related]
34. 18F-FDG imaging: pitfalls and artifacts. Abouzied MM; Crawford ES; Nabi HA J Nucl Med Technol; 2005 Sep; 33(3):145-55; quiz 162-3. PubMed ID: 16145222 [TBL] [Abstract][Full Text] [Related]
35. Atlas of confounding factors in head and neck PET/CT imaging. Bhargava P; Rahman S; Wendt J Clin Nucl Med; 2011 May; 36(5):e20-9. PubMed ID: 21467845 [TBL] [Abstract][Full Text] [Related]
36. "Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763). Schinagl DA; Troost EG; Kaanders JH Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1629; author reply 1629. PubMed ID: 19515513 [No Abstract] [Full Text] [Related]
37. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066 [TBL] [Abstract][Full Text] [Related]
38. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes. Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956 [TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors]. Li XP; Liang Y; Liu X; Wang QS; Wu HB Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869 [TBL] [Abstract][Full Text] [Related]
40. Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning. Sam S; Shon IH; Vinod SK; Lin P; Lin M J Nucl Med Technol; 2012 Sep; 40(3):175-7. PubMed ID: 22582005 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]